QSI vs. TRNS, EYPT, ALNT, LAB, CTKB, AEHR, SENS, QTRX, MASS, and FEIM
Should you be buying Quantum-Si stock or one of its competitors? The main competitors of Quantum-Si include Transcat (TRNS), Eyepoint Pharmaceuticals (EYPT), Allient (ALNT), Standard BioTools (LAB), Cytek Biosciences (CTKB), Aehr Test Systems (AEHR), Senseonics (SENS), Quanterix (QTRX), 908 Devices (MASS), and Frequency Electronics (FEIM). These companies are all part of the "measuring and control equipment" industry.
Quantum-Si vs. Its Competitors
Quantum-Si (NASDAQ:QSI) and Transcat (NASDAQ:TRNS) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, valuation, dividends, profitability and analyst recommendations.
Transcat has a net margin of 5.21% compared to Quantum-Si's net margin of -2,925.41%. Transcat's return on equity of 6.47% beat Quantum-Si's return on equity.
39.9% of Quantum-Si shares are owned by institutional investors. Comparatively, 98.3% of Transcat shares are owned by institutional investors. 30.0% of Quantum-Si shares are owned by insiders. Comparatively, 2.3% of Transcat shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Transcat has higher revenue and earnings than Quantum-Si. Quantum-Si is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.
In the previous week, Transcat had 1 more articles in the media than Quantum-Si. MarketBeat recorded 2 mentions for Transcat and 1 mentions for Quantum-Si. Quantum-Si's average media sentiment score of 0.93 beat Transcat's score of 0.70 indicating that Quantum-Si is being referred to more favorably in the media.
Quantum-Si presently has a consensus price target of $3.48, indicating a potential upside of 97.44%. Transcat has a consensus price target of $112.20, indicating a potential upside of 38.02%. Given Quantum-Si's stronger consensus rating and higher probable upside, equities analysts plainly believe Quantum-Si is more favorable than Transcat.
Quantum-Si has a beta of 2.89, meaning that its stock price is 189% more volatile than the S&P 500. Comparatively, Transcat has a beta of 0.73, meaning that its stock price is 27% less volatile than the S&P 500.
Summary
Transcat beats Quantum-Si on 10 of the 16 factors compared between the two stocks.
Get Quantum-Si News Delivered to You Automatically
Sign up to receive the latest news and ratings for QSI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding QSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Quantum-Si Competitors List
Related Companies and Tools
This page (NASDAQ:QSI) was last updated on 7/18/2025 by MarketBeat.com Staff
